Market Closed - Nasdaq Stockholm 10:09:57 2024-04-26 am EDT 5-day change 1st Jan Change
1.78 SEK +4.09% Intraday chart for ScandiDos AB +5.33% -12.32%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Sweden's ScandiDos Gets Radiation Therapy Device Orders from China; Shares Up MT
ScandiDos Receives Orders Worth EUR 478,000 from China CI
ScandiDos AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI
ScandiDos Achieves EU Medical Device Regulation Certification for the Delta4 Phantom+ Product Line CI
ScandiDos AB Reports Earnings Results for the First Quarter Ended July 31, 2023 CI
ScandiDos Receives Orders Worth EUR290,000 from China CI
ScandiDos AB Reports Earnings Results for the Full Year Ended April 30, 2023 CI
ScandiDos AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2023 CI
ScandiDos AB and IBA Dosimetry Deepen Strategic Alliance! CI
ScandiDos Receives an Order Worth EUR 263 Million from China CI
ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023 CI
ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023 CI
ScandiDos AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022 CI
ScandiDos AB Receives an Order of EUR 377, 500 from Japan CI
ScandiDos AB Reports Earnings Results for the First Quarter Ended July 31, 2022 CI
IBA S.A. and ScandiDos A.B. Form Strategic Alliance to Increase Access to Safe Radiotherapy CI
ScandiDos AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2022 CI
ScandiDos AB Reports Earnings Results for the Full Year Ended April 30, 2022 CI
ScandiDos AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022 CI
ScandiDos Launches Delta4 Insight Which Is Immediately Available to Sell to Customers in Europe and Parts of Asia CI
ScandiDos AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021 CI
Scandidos AB Publ Reports Earnings Results for the First Quarter Ended July 31, 2021 CI
Spore Invest AB acquired 10.01% stake in ScandiDos AB (OM:SDOS) from Fårö Capital AB. CI
Scandidos AB Publ Reports Earnings Results for the Fourth Quarter Ended April 30, 2021 CI
Chart ScandiDos AB
More charts
ScandiDos AB is a Sweden-based company active within the medical equipment sector. The Company's competence includes the design and development of radiation detectors, electrometers and application software, as well as clinical experience in medical physics and radiation measurements. The Company's business focuses on developing such applications as Arc Therapy - IMAT/VMAT, Tomotherapy, IMRT and Machine QA, among others. ScandiDos AB markets its products under the Delta4 brand. Delta4 offers Delta4AT - At Treatment in-vivo dosimetry for advanced RT and Delta4PT - Pre Treatment volumetric plan QA, among others. It operates in Europe, Asia, North America and Asia, and through numerous distributors and subsidiaries, including Additec GmbH and Conmedica GmbH in Germany, and ScandiDos SAS in France.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SDOS Stock
  4. News ScandiDos AB
  5. Sweden's ScandiDos Gets Radiation Therapy Device Orders from China; Shares Up